The evolution of inflammatory disease

  • March 21, 2013
The evolution of inflammatory disease

Towfique Raj is lead author on a paper investigating the evolution of inflammatory diseases such as multiple sclerosis.

Some variants in our genes that contribute to a person’s risk for inflammatory diseases such as multiple sclerosis, Crohn’s disease or rheumatoid arthritis, have been the target of natural selection over the course of human history, according to a study led by Gates Cambridge Alumnus Towfique Raj [2005].

He was part of a research team from Brigham and Women’s Hospital, led by Philip De Jager, MD, PhD,  BWH Department of Neurology and Barbara Stranger, PhD, University of Chicago. The research, which has been published this week in the online issue of The American Journal of Human Genetics, looked at genome-wide association studies along with protein-protein interaction networks, as well as other data and found 21 places in the genome that bear a ‘signature’ for both inflammatory disease susceptibility and natural selection.

Towfique Raj from BWH’s Department of Neurology and Harvard Medical School, is the lead author on this study. The findings suggest that, in the past, these variants rose in frequency in the human population to help protect humans against viruses, bacteria and other pathogens. But now in our cleaner modern world, the environment and exposure to pathogens has changed, and the genetic variants that were originally meant to protect us, now make an autoimmune reaction more likely. These results are consistent with the hygiene hypothesis in which our cleaner environment is thought to contribute to the increasing prevalence of inflammatory diseases.

Towfique, who did a PhD in Genetics at the University of Cambridge, said: “Interestingly, the selection events we look at are recent (within the last 2,000 years or so) and it seems that one interconnected pathway implicated in multiple inflammatory disease has been under selection. Given the fact that we have recorded human history for this period, we have also been able to make a speculative comment regarding bubonic plague as one possible pathogen that could have played a role since all of this work focused on European populations, in which the disease-associated variants have been discovered.”

This research was supported by the National Institutes of Health.  To access the paper, click here.

Picture of Yersinia pestis which causes bubonic plague: NIAID-flickr and Creative Commons.

Latest News

Celebrating agricultural innovation in Africa

A foundation started by a Gates Cambridge Scholar is leading a Cambridge Festival event in March to celebrate agricultural innovation in Africa where a new project on food security will be launched. The Agri-Innovation & Impact Project (AGRIIP) will be launched at the Roots of Resilience event on 27th March. It is designed to empower […]

What makes Earth tick

It was during his master’s that Alex Myhill [2022] was introduced to Earth Science and realised just how much we don’t understand about the Earth. He wanted to explore further and his PhD seeks to understand the dynamics that make the Earth tick. He is developing new techniques for the efficient computation of whole Earth […]

25th anniversary panel to speak at Cambridge Festival

Five Scholars will speak about their ideas that could change the world at this year’s Cambridge Festival as part of the ongoing celebrations for Gates Cambridge’s 25th anniversary. The Festival programme has been published today and includes the Gates Cambridge event – Ideas that could change the world – hosted by international journalist Catherine Galloway […]

Study shows need for repeated vaccines for immunocompromised people

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, according to new research from the University of Cambridge led by a Gates Cambridge Scholar. The findings, published today in Science Advances, suggest that such individuals will need regular vaccine […]